1 Oct 2026, 18:23
Substantial Holders—
BDXBCAL DIAGNOSTICS LIMITED
Announcement history available from 1 August 2025
Fromto
30 Sept 2026, 08:48
Company UpdateMS
23 Sept 2026, 10:43
Company UpdateMS
18 Sept 2026, 08:22
Meetings & Governance—
18 Sept 2026, 08:22
Meetings & Governance—
10 Sept 2026, 13:19
Other—
3 Sept 2026, 12:40
Company Administration—
3 Sept 2026, 11:47
Presentations—
31 Aug 2026, 14:30
Presentations—
28 Aug 2026, 15:46
Company Administration—
28 Aug 2026, 15:44
Financial ResultsMS
26 Aug 2026, 08:57
Substantial HoldersMS
26 Aug 2026, 08:35
Other—
25 Aug 2026, 18:53
Securities Administration—
21 Aug 2026, 18:27
Securities Administration—
21 Aug 2026, 18:18
Securities Administration—
21 Aug 2026, 18:14
Periodic ReportsMS
6 Aug 2026, 09:34
Presentations—
30 July 2026, 08:38
Quarterly ReportsMS
14 July 2026, 18:51
Securities Administration—
14 July 2026, 18:44
Securities Administration—
14 July 2026, 18:32
Securities Administration—
14 July 2026, 18:20
Securities Administration—
2 July 2026, 17:13
Other—
2 July 2026, 10:04
Company UpdateMS
29 June 2026, 09:57
Periodic ReportsMS
18 June 2026, 09:52
Company UpdateMS
28 May 2026, 08:25
Company Update—
19 May 2026, 10:09
Company UpdateMS
11 May 2026, 08:23
Company AdministrationMS
22 Apr 2026, 08:50
Quarterly ReportsMS
31 Mar 2026, 09:11
Company Update—
26 Mar 2026, 09:19
Company UpdateMS
20 Mar 2026, 17:08
Director Interests—
19 Mar 2026, 17:21
Director Interests—
17 Mar 2026, 15:31
Director Interests—
6 Mar 2026, 15:21
Securities Administration—
6 Mar 2026, 15:14
Securities Administration—
20 Feb 2026, 19:26
Director Interests—
18 Feb 2026, 11:33
Financial Results—
17 Feb 2026, 19:47
Financial ResultsMS
13 Feb 2026, 10:13
Presentations—
5 Feb 2026, 08:24
Company UpdateMS
3 Feb 2026, 08:45
Director Interests—
27 Jan 2026, 08:51
Company Administration—
21 Jan 2026, 08:53
Quarterly ReportsMS
19 Jan 2026, 15:23
Substantial Holders—
15 Dec 2025, 08:19
Securities Administration—
9 Dec 2025, 08:23
Company Update—
3 Dec 2025, 08:28
Company Update—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 1 Oct 2026, 18:23 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 30 Sept 2026, 08:48 | BREASTESTplus 2 clinically validated | Company Update | MS | 11001 | |
| 23 Sept 2026, 10:43 | BCAL Introduces Avantect Multi-Cancer Early Detection Test | Company Update | MS | 11001 | |
| 18 Sept 2026, 08:22 | Letter to Shareholders re Annual General Meeting | Meetings & Governance | — | 08006, 16002 | |
| 18 Sept 2026, 08:22 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 10 Sept 2026, 13:19 | Clarification of BCAL's Position in Relation to GSS | Other | — | 11004 | |
| 3 Sept 2026, 12:40 | BCAL Seeks Board Change at Genetic Signatures | Company Administration | — | 12008 | |
| 3 Sept 2026, 11:47 | Investor Presentation September 2026 | Presentations | — | 03026 | |
| 31 Aug 2026, 14:30 | Meet The CEO FY 2026 Results Webinar 3 Sept 2026 at 1PM | Presentations | — | 14014 | |
| 28 Aug 2026, 15:46 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 28 Aug 2026, 15:44 | Appendix 4E and Annual Report to shareholders | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 26 Aug 2026, 08:57 | BCAL Takes Interest in Genetic Signatures to 18.46% | Substantial Holders | MS | 02006 | |
| 26 Aug 2026, 08:35 | Change in Substantial Shareholder Notice for GSS | Other | — | — | |
| 25 Aug 2026, 18:53 | Notification regarding unquoted securities - BDX | Securities Administration | — | 06021 | |
| 21 Aug 2026, 18:27 | Notification regarding unquoted securities - BDX | Securities Administration | — | 06021 | |
| 21 Aug 2026, 18:18 | Proposed issue of securities - BDX | Securities Administration | — | 06013 | |
| 21 Aug 2026, 18:14 | BCAL Secures Funding for FY2027 Update | Periodic Reports | MS | 03014, 06009 | |
| 6 Aug 2026, 09:34 | Bioshares Conference Investor Presentation | Presentations | — | 03026 | |
| 30 July 2026, 08:38 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 14 July 2026, 18:51 | Notification regarding unquoted securities - BDX | Securities Administration | — | 06021 | |
| 14 July 2026, 18:44 | Notification regarding unquoted securities - BDX | Securities Administration | — | 06021 | |
| 14 July 2026, 18:32 | Notification regarding unquoted securities - BDX | Securities Administration | — | 06021 | |
| 14 July 2026, 18:20 | Notification regarding unquoted securities - BDX | Securities Administration | — | 06021 | |
| 2 July 2026, 17:13 | Becoming a substantial holder for GSS | Other | — | — | |
| 2 July 2026, 10:04 | BCAL to Acquire Shares in Genetic Signatures | Company Update | MS | 11001 | |
| 29 June 2026, 09:57 | BCAL Secures Funding for FY2027 | Periodic Reports | MS | 03014, 06009 | |
| 18 June 2026, 09:52 | BCAL Develops New Blood Test for Breast Cancer Recurrence | Company Update | MS | 11001 | |
| 28 May 2026, 08:25 | Validation Agreement Signed with Sonic USA, for Breastest V2 | Company Update | — | 11001 | |
| 19 May 2026, 10:09 | BCAL Launches Early Detection Cancer Platform | Company Update | MS | 11001 | |
| 11 May 2026, 08:23 | BCAL Appoints Anne-Louise Arnett as Chief Executive Officer | Company Administration | MS | 12017, 12019 | |
| 22 Apr 2026, 08:50 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 31 Mar 2026, 09:11 | BCAL Submits MSAC Application for Avantect Pancreatic Test | Company Update | — | 11001 | |
| 26 Mar 2026, 09:19 | BCAL Accelerates Rollout of Avantect Early Detection Tests | Company Update | MS | 11001 | |
| 20 Mar 2026, 17:08 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 19 Mar 2026, 17:21 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 17 Mar 2026, 15:31 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 6 Mar 2026, 15:21 | Cleansing Notice | Securities Administration | — | 06018 | |
| 6 Mar 2026, 15:14 | Application for quotation of securities - BDX | Securities Administration | — | 06020 | |
| 20 Feb 2026, 19:26 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 18 Feb 2026, 11:33 | BCAL Half Year Results Presentation December 2025 | Financial Results | — | 03004, 03026 | |
| 17 Feb 2026, 19:47 | Half Yearly Report and Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 13 Feb 2026, 10:13 | BCAL Webinar Review Half Year Results 18 February 11am AEDT | Presentations | — | 14014 | |
| 5 Feb 2026, 08:24 | Shareholder Update | Company Update | MS | 11001 | |
| 3 Feb 2026, 08:45 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 27 Jan 2026, 08:51 | Mr Mark McConnell Appointed to the Board | Company Administration | — | 12001 | |
| 21 Jan 2026, 08:53 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19002, 19007 | |
| 19 Jan 2026, 15:23 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 15 Dec 2025, 08:19 | Application for quotation of securities - BDX | Securities Administration | — | 06020 | |
| 9 Dec 2025, 08:23 | Pancreatic and Ovarian Cancer Early Detection Blood Testing | Company Update | — | 11001 | |
| 3 Dec 2025, 08:28 | Ethics Approval to Establish BREASTEST Registry | Company Update | — | 11001 |
1–50 of 71
1 / 2